Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors

Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors

<p>Abstract</p> <p>Background</p> <p>Microarray Comparative Genomic Hybridization (array CGH) provides a means to examine DNA copy number aberrations. Various platforms, brands and underlying technologies are available, facing the user with many choices regarding platfo...

Full description

Bibliographic Details
Main Authors: Naume B, Gunderson K, Bruhn L, Sun H, Hicks J, Johansen FE, Aarøe J, Baumbusch LO, Kristensen VN, Liestøl K, Børresen-Dale A-L, Lingjærde OC
Format: Article
Language:English
Published: BMC 2008-08-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/9/379

Similar Items

Similar Items